Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jul 1;98(1):100–107. doi: 10.1172/JCI118753

Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.

J Gaschet 1, A Lim 1, L Liem 1, R Vivien 1, M M Hallet 1, J L Harousseau 1, J Even 1, E Goulmy 1, M Bonneville 1, N Milpied 1, H Vié 1
PMCID: PMC507405  PMID: 8690780

Abstract

Analysis of a large number of unrelated bone marrow transplantations (BMT) has shown that HLA-DP incompatibility did not detectably influence the risk for acute graft-versus-host disease (aGVHD). Accordingly, it was proposed that HLA-DP determinants did not function as transplantation antigens in the same way as HLA-A, -B, or -DR. We have previously shown that HLA-DP (as well as HLA-A, -B, -DQ, or -DR)-specific T cells could be isolated from skin biopsies of patients who developed an aGVHD after semiallogeneic BMT. Nevertheless, whether a single HLA-DP mismatched allele could induce a detectable allo-specific reaction in vivo after BMT remained to be established. To directly address this issue we studied one patient who presented aGVHD after receiving purified CD34+ bone marrow (BM) cells from an unrelated donor with a single HLA-DP mismatch in the GVHD direction. To characterize the immunological events associated with GVHD, we analyzed the peripheral T cell repertoire, the T cell receptor Vbeta diversity, and the specificity of T cells invading a skin biopsy at the onset of GVHD. Our results demonstrated that a large fraction of skin-infiltrating lymphocytes, which expressed diverse T cell receptors, were reactive against this single HLA-DPB1 *0501 mismatch and consequently that a single HLA-DP mismatch between BM donor and recipient can activate a strong T cell response in vivo.

Full Text

The Full Text of this article is available as a PDF (231.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anasetti C., Beatty P. G., Storb R., Martin P. J., Mori M., Sanders J. E., Thomas E. D., Hansen J. A. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol. 1990 Oct;29(2):79–91. doi: 10.1016/0198-8859(90)90071-v. [DOI] [PubMed] [Google Scholar]
  2. Apperley J. F., Mauro F. R., Goldman J. M., Gregory W., Arthur C. K., Hows J., Arcese W., Papa G., Mandelli F., Wardle D. Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect. Br J Haematol. 1988 Jun;69(2):239–245. doi: 10.1111/j.1365-2141.1988.tb07628.x. [DOI] [PubMed] [Google Scholar]
  3. Ash R. C., Casper J. T., Chitambar C. R., Hansen R., Bunin N., Truitt R. L., Lawton C., Murray K., Hunter J., Baxter-Lowe L. A. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med. 1990 Feb 22;322(8):485–494. doi: 10.1056/NEJM199002223220801. [DOI] [PubMed] [Google Scholar]
  4. Beatty P. G., Anasetti C., Hansen J. A., Longton G. M., Sanders J. E., Martin P. J., Mickelson E. M., Choo S. Y., Petersdorf E. W., Pepe M. S. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood. 1993 Jan 1;81(1):249–253. [PubMed] [Google Scholar]
  5. Beatty P. G., Clift R. A., Mickelson E. M., Nisperos B. B., Flournoy N., Martin P. J., Sanders J. E., Stewart P., Buckner C. D., Storb R. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med. 1985 Sep 26;313(13):765–771. doi: 10.1056/NEJM198509263131301. [DOI] [PubMed] [Google Scholar]
  6. Beatty P. G., Hansen J. A., Longton G. M., Thomas E. D., Sanders J. E., Martin P. J., Bearman S. I., Anasetti C., Petersdorf E. W., Mickelson E. M. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation. 1991 Feb;51(2):443–447. doi: 10.1097/00007890-199102000-00034. [DOI] [PubMed] [Google Scholar]
  7. Borrelli E., Heyman R., Hsi M., Evans R. M. Targeting of an inducible toxic phenotype in animal cells. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7572–7576. doi: 10.1073/pnas.85.20.7572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dietrich P. Y., Caignard A., Diu A., Genevee C., Pico J. L., Henry-Amar M., Bosq J., Angevin E., Triebel F., Hercend T. Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host disease. Blood. 1992 Nov 1;80(9):2419–2424. [PubMed] [Google Scholar]
  9. Dietrich P. Y., Caignard A., Lim A., Chung V., Pico J. L., Pannetier C., Kourilsky P., Hercend T., Even J., Triebel F. In vivo T-cell clonal amplification at time of acute graft-versus-host disease. Blood. 1994 Oct 15;84(8):2815–2820. [PubMed] [Google Scholar]
  10. Even J., Lim A., Puisieux I., Ferradini L., Dietrich P. Y., Toubert A., Hercend T., Triebel F., Pannetier C., Kourilsky P. T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor beta-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases. Res Immunol. 1995 Feb;146(2):65–80. doi: 10.1016/0923-2494(96)80240-9. [DOI] [PubMed] [Google Scholar]
  11. Ferrara J. L., Deeg H. J. Graft-versus-host disease. N Engl J Med. 1991 Mar 7;324(10):667–674. doi: 10.1056/NEJM199103073241005. [DOI] [PubMed] [Google Scholar]
  12. Gaschet J., Denis C., Milpied N., Hallet M. M., Davodeau F., Necker A., Romagné F., Bonneville M., Vié H. Analysis of T-cell receptor V beta expression among V alpha subsets. Evidence for tight regulation of the combinatorial diversity. Ann N Y Acad Sci. 1995 Jul 7;756:84–86. doi: 10.1111/j.1749-6632.1995.tb44485.x. [DOI] [PubMed] [Google Scholar]
  13. Gaschet J., Mahé B., Milpied N., Devilder M. C., Dréno B., Bignon J. D., Davodeau F., Hallet M. M., Bonneville M., Vié H. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation. J Clin Invest. 1993 Jan;91(1):12–20. doi: 10.1172/JCI116160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gaschet J., Treviño M. A., Cherel M., Vivien R., Garcia-Sahuquillo A., Hallet M. M., Bonneville M., Harrousseau J. L., Bragado R., Milpied N. HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease. Blood. 1996 Mar 15;87(6):2345–2353. [PubMed] [Google Scholar]
  15. Goulmy E., Schipper R., Pool J., Blokland E., Falkenburg J. H., Vossen J., Gratwohl A., Vogelsang G. B., van Houwelingen H. C., van Rood J. J. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med. 1996 Feb 1;334(5):281–285. doi: 10.1056/NEJM199602013340501. [DOI] [PubMed] [Google Scholar]
  16. Hansen J. A., Anasetti C., Beatty P. G., Martin P. J., Sanders J. E., Storb R., Thomas E. D. Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival. Bone Marrow Transplant. 1990 Jul;6 (Suppl 1):108–111. [PubMed] [Google Scholar]
  17. Horowitz M. M., Gale R. P., Sondel P. M., Goldman J. M., Kersey J., Kolb H. J., Rimm A. A., Ringdén O., Rozman C., Speck B. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990 Feb 1;75(3):555–562. [PubMed] [Google Scholar]
  18. Kolb H. J., Schattenberg A., Goldman J. M., Hertenstein B., Jacobsen N., Arcese W., Ljungman P., Ferrant A., Verdonck L., Niederwieser D. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood. 1995 Sep 1;86(5):2041–2050. [PubMed] [Google Scholar]
  19. Mackinnon S., Papadopoulos E. B., Carabasi M. H., Reich L., Collins N. H., Boulad F., Castro-Malaspina H., Childs B. H., Gillio A. P., Kernan N. A. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood. 1995 Aug 15;86(4):1261–1268. [PubMed] [Google Scholar]
  20. Martin P. J. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors. Bone Marrow Transplant. 1991 Sep;8(3):217–223. [PubMed] [Google Scholar]
  21. Moreau P., Cesbron A. HLA-DP and allogeneic bone marrow transplantation. Bone Marrow Transplant. 1994 Jun;13(6):675–681. [PubMed] [Google Scholar]
  22. Pannetier C., Cochet M., Darche S., Casrouge A., Zöller M., Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci U S A. 1993 May 1;90(9):4319–4323. doi: 10.1073/pnas.90.9.4319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pannetier C., Delassus S., Darche S., Saucier C., Kourilsky P. Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res. 1993 Feb 11;21(3):577–583. doi: 10.1093/nar/21.3.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Petersdorf E. W., Smith A. G., Mickelson E. M., Longton G. M., Anasetti C., Choo S. Y., Martin P. J., Hansen J. A. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood. 1993 Apr 1;81(7):1923–1932. [PubMed] [Google Scholar]
  25. Storb R., Deeg H. J., Whitehead J., Appelbaum F., Beatty P., Bensinger W., Buckner C. D., Clift R., Doney K., Farewell V. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med. 1986 Mar 20;314(12):729–735. doi: 10.1056/NEJM198603203141201. [DOI] [PubMed] [Google Scholar]
  26. Tiberghien P., Reynolds C. W., Keller J., Spence S., Deschaseaux M., Certoux J. M., Contassot E., Murphy W. J., Lyons R., Chiang Y. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood. 1994 Aug 15;84(4):1333–1341. [PubMed] [Google Scholar]
  27. Weiden P. L., Sullivan K. M., Flournoy N., Storb R., Thomas E. D. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med. 1981 Jun 18;304(25):1529–1533. doi: 10.1056/NEJM198106183042507. [DOI] [PubMed] [Google Scholar]
  28. van Lochem E. G., Bakker A., Snijder S., Aarts M., de Gast G. C., Goulmy E. Epstein-Barr virus infection abrogates the stimulatory capacity of B cells to a major histocompatibility complex class-II-restricted proliferative T-cell clone. Hum Immunol. 1995 Feb;42(2):137–144. doi: 10.1016/0198-8859(94)00091-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES